Lifecore Biomedical, Inc. (LFCR) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day, and welcome to the LifeCorps Biomedical Fourth Quarter 2025 Earnings Conference Call. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a question-and-answer session. Instructions will be given at that time. Please note this call is being recorded. I would now like to turn the call over to Stephanie Diaz, Manager of Investor Relations. Please go ahead. Good morning, and thank you for joining us. Today, LifeCore Biomedical will provide its earnings results for the fourth quarter and transition period ended December 31st, 2025 and a corporate update. As the company has recently changed its fiscal year end to align with the calendar year, we will be comparing our 2025 results to the closest comparable period in the prior year. Today, we will be comparing our fourth quarter ended December 31st, 2025 with the previously reported quarter ended November 24th, 2024. We will be comparing our seven-month transition period ended December 31st, 2025, with the unaudited seven-month period ended December 31st, 2024. Hosting the call today from LifeCorps are Paul Josephs, President and Chief Executive Officer, and Ryan Lake, Chief Financial Officer. Before we begin, we'd like to remind everyone that today's conference call will contain forward-looking statements. It is important to note that the forward-looking statements made during this call reflect management's judgment and analysis only as of today, March 16, 2026, and the company's actual results could differ materially from those projected in such forward-looking statements. For a more thorough discussion of the risks and uncertainties associated with any forward-looking statements, please see the disclaimer regarding forward-looking statements that is included i...